# Ademetionine in Obstructive Hypertrophic Cardiomyopathy

> **NCT07367724** · PHASE2 · RECRUITING · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 44 (estimated)

## Conditions studied

- Obstructive Hypertrophic Cardiomyopathy (oHCM)

## Interventions

- **DRUG:** Ademetionine 1,4-Butanedisulfonate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07367724
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07367724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07367724, "Ademetionine in Obstructive Hypertrophic Cardiomyopathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07367724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*